# url

id: cord-304623-j9ay4jkf
domain: www.pirbright.ac.uk
url:
  https://www.pirbright.ac.uk/news/2019/11/bill-melinda-gates-foundation-funds-development-pirbright%e2%80%99s-livestock-antibody-hub


id: cord-304623-j9ay4jkf
domain: portal.nifa.usda.gov
url:
  https://portal.nifa.usda.gov/web/crisprojectpages/1016686-immune-reagents-for-ruminants-with-primary-focus-on-bovine-specific-reagents.html


id: cord-304623-j9ay4jkf
domain: www.vetvaccnet.ac.uk
url:
  http://www.vetvaccnet.ac.uk/publications/veterinaryimmunology-toolbox-meeting-uk-veterinary-vaccinologynetwork)


id: cord-332150-j76726no
domain: investor.regeneron.com
url:
  https://investor.regeneron.com/newsreleases/news-release-details/regeneron-and-sanofi-provideupdate-us-phase-23-adaptive)


id: cord-320474-jyk7zphp
domain: www.biospace.com
url:
  https://www.biospace.com/article/releases/i-mab-announcesind-clearance-from-fda-for-tjm2-to-treat-cytokine-release-syndrome-crsassociated-with-severe-coronavirus-disease-19-covid-19-


# ent

id: cord-020770-wpub7krf
sid: 388
eid: 1
type: PERSON
entity:
  über die morphologie und biologie der abraümzellen im zentralnervesystem étude de la stéatose interstitielle diffuse de l'encéphale chez le nouveau-né


id: cord-320474-jyk7zphp
sid: 139
eid: 1
type: GPE
entity:
  https://www.biospace.com/article/releases/i-mab-announcesind-clearance-from-fda-for-tjm2-to-treat-cytokine-release-syndrome-crsassociated-with-severe-coronavirus-disease-19-covid-19-/


# pos

id: cord-304623-j9ay4jkf
sid: 91
tid: 12
pos: PROPN
token:
  http://www.vetvaccnet.ac.uk/publications/veterinaryimmunology-toolbox-meeting-uk-veterinary-vaccinologynetwork

lemma:
  http://www.vetvaccnet.ac.uk/publications/veterinaryimmunology-toolbox-meeting-uk-veterinary-vaccinologynetwork


id: cord-332150-j76726no
sid: 52
tid: 29
pos: NOUN
token:
  https://investor.regeneron.com/newsreleases/news-release-details/regeneron-and-sanofi-provideupdate-us-phase-23-adaptive

lemma:
  https://investor.regeneron.com/newsreleases/news-release-details/regeneron-and-sanofi-provideupdate-us-phase-23-adaptive


